MTH | Ticker Profile - Titan Protect

MTH

Meritage Homes Corporation

Consumer Cyclical · Residential Construction · NYQ

$68.33

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$4.4B

Total market value of the company

Trailing P/E

12.13

Reasonably valued

Forward P/E

10.18

Based on estimated future earnings — lower means cheaper

Rev Growth

-17.7%

Year-over-year revenue change

Profit Margin

6.9%

How much profit the company keeps from each dollar of revenue

ROE

7.5%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$80.00

+17% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 9 analysts covering this stock

About Meritage Homes Corporation

Meritage Homes Corporation, together with its subsidiaries, designs and builds single-family attached and detached homes in the United States. The company operates through two segments: Homebuilding and Financial Services. It acquires and develops land; and constructs, markets, and sells homes for entry-level and first move-up buyers in Arizona, California, Colorado, Utah, Texas, Alabama, Florida, Georgia, Mississippi, North Carolina, South Carolina, and Tennessee. The company also provides title and escrow, mortgage, insurance, title insurance, and closing/settlement services to its homebuyers. Meritage Homes Corporation was founded in 1985 and is based in Scottsdale, Arizona.

https://www.meritagehomes.com

Country: United States Employees: 1,860 Industry: Residential Construction

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

DISTRIBUTION

Smart money appears to be selling into strength — caution

Sharpe Ratio

-0.088

Returns do not compensate for the risk — negative edge

Kelly Fraction

-0.0163

No positive edge detected — the data suggests staying out

Calmar Ratio

-0.237

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-10.2%

Historical annualised return based on price data

Max Drawdown

-43.0%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.43

Moves slightly more than the broader market

52W High

$84.74

19% below the year high

52W Low

$58.03

18% above the year low

Avg Volume

947,324

Average daily shares traded — higher means easier to buy and sell

Short Ratio

3.3

Days it would take all short sellers to cover — higher means more crowded

Short % Float

6.9%

Moderate short interest

Div Yield

289.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$5.48

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

37.34

Heavy leverage — higher financial risk if revenues decline

Current Ratio

14.97

Strong balance sheet — comfortably covers short-term obligations

Quick Ratio

2.15

Like current ratio but excludes inventory — stricter test

Gross Margin

19.1%

Revenue left after cost of goods — higher means pricing power

Operating Margin

5.8%

Profit from core operations before interest and tax

Free Cash Flow

$139M

Positive — the business generates more cash than it spends

Revenue (TTM)

$5.6B

Total revenue over the last 12 months

Net Income

$386M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$90.00

Target Median

$80.00

Target Low

$58.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go